DEFIANCE NEXT GEN ALTERED EXPERIENCE ETF - USD Investment objective
PSY is the first US-listed psychedelic ETF. It seeks to track the BITA Medical Psychedelics, Cannabis, and Ketamine Index, a rules-based index that tracks the performance of companies, listed in North American Exchanges, that operate business models focused on the usage of Psychedelics, Medical Cannabis, and Ketamine for medicinal and health treatment purposes. It is a weighted, rules-based index that has the potential to mitigate risk of over-exposure to any single company.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 3.53 CAD | +2.62% | +8.95% | +27.44% | 9.99% | ||
| 1.93 USD | +4.89% | +4.32% | +36.88% | 7.91% | ||
| 97.71 USD | -0.17% | +3.69% | -3.08% | 6.61% | ||
| 7.94 USD | +1.02% | -5.25% | -9.26% | 6.55% | ||
| 2.45 CAD | -2.00% | -0.81% | +122.73% | 5.94% | ||
| 2.22 USD | +0.91% | +5.21% | -11.55% | 5.34% | ||
| 10.51 USD | +0.10% | -4.71% | +81.21% | 5.21% | ||
More news
In partnership with
Description
| US26922B8081 | |
|---|---|
| Total Expense Ratio |
